Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)

Hooper CY, Smith WJ

Therapeutics and Clinical Risk Management 2012, 8:131-137

Published Date: 16 March 2012